Translated and edited from: Martin Woodbridge, A Primer to Medicinal Cannabis (Bedrocan, 2018). Supporting sources are listed under References at the end.
Most writing about the safety of medical cannabis asks what it might treat. This article asks a different question: who should not use it, and who needs extra care. That list is short and well described. Patients usually look it up last. Part 1 explains the key terms and then covers mental illness, heart disease, liver disease and older patients.
Read this first. Nothing below is medical advice, and nothing below is a self-assessment tool. In Thailand, cannabis flower is a controlled herb under the Notification of the Ministry of Public Health Re: Controlled Herbs (Cannabis), B.E. 2568, in force since 26 June 2025. It can be sold only against a prescription on form PT 33 (ภ.ท.33), and one prescription covers at most 30 days. The prescription must come from an authorised practitioner. This can be a medical doctor, dentist, pharmacist, Thai traditional medicine practitioner, applied Thai traditional medicine practitioner, Chinese medicine practitioner or licensed folk healer.
Everything on this page is something to raise with that practitioner. None of it is a reason to start, stop or change a treatment on your own. Stopping a prescribed medicine suddenly can be more dangerous than the risk you are trying to avoid. If something here applies to you, write it down and take the note to your next appointment.
Contraindication and precaution: two different words
A contraindication means a medicine should not be used at all. The harm you can expect is greater than any benefit you can expect.
A precaution (also called a relative contraindication) means the medicine may still be suitable, but with changes. These can include a lower starting dose, more frequent check-ups, a different mix of cannabinoids or a different way of taking it.
Very few situations in medical cannabis are absolute contraindications. Most are precautions. In practice, most items on this list mean “tell your prescriber and agree a plan”, not “never”.
How solid the evidence is
Guidance on medical cannabis is less settled than guidance on older groups of medicines, because fewer clinical trials have been done. Much of what follows does not come from randomised trials. In a randomised trial, chance decides which patients get the medicine and which get a comparison. Instead, much of the guidance comes from three weaker kinds of evidence:
- pharmacology: what is known about how the drug acts in the body;
- observational studies: researchers follow patients but do not decide who gets which treatment;
- prescriber consensus: what experienced prescribers broadly agree on.
What to do with this: be careful with any online claim that cannabis is “proven safe” or “proven dangerous” for a condition. Ask your prescriber what the current guidance says for your case.
Where this list comes from
The main source is the 2018 handbook A Primer to Medicinal Cannabis by Martin Woodbridge. He is a pharmacologist, policy analyst and clinical educator, and in 2007 he wrote New Zealand’s medicinal cannabis guidelines for its Ministry of Health. Its publisher, Bedrocan, is a Dutch company that produces medicinal cannabis. This article calls the book “the Primer”. It includes interviews with two Dutch professionals. One is a pain physician, a doctor who specialises in treating long-term pain. The other is a dispensing pharmacist, the pharmacist who hands the medicine to the patient.
Two points that apply to every group below
First, most of the risk comes from THC. THC is the cannabinoid that causes the high. Most of the risks to mental state, mental health and the heart come from THC. For this reason, guidance for higher-risk patients leans towards CBD-predominant products, which contain mostly CBD and little or no THC.
CBD has its own risks. It slows a group of liver enzymes called CYP enzymes (cytochrome P450). These enzymes break down many common medicines. When CBD slows them, other medicines can build up in the blood. This is how CBD causes most interactions between cannabis and other medicines.
CBD has also been linked to raised liver enzymes on blood tests. This is a sign that the liver is under strain. It shows up especially in people who also take valproate, a medicine for seizures. So a switch to a CBD-predominant product still needs check-ups.
Second, most side effects depend on the dose and the route. The route is how the medicine enters the body: inhaled, swallowed, or placed under the tongue or on the skin. Each route behaves differently, and higher doses bring more side effects. That is why prescribing guidance says start low, go slow: begin with a small dose and raise it slowly.
What you can do: ask your prescriber which product, which THC-to-CBD balance and which route they chose for you, and why. If you know the reasons, you can tell sooner when something is not going as planned.
History of psychosis or serious mental illness
This is the clearest caution in the published literature, and the one where sources disagree least.
Psychosis means losing touch with reality, for example hearing voices or firmly believing things that are not true. THC can trigger psychotic symptoms. The Primer says plainly that medical cannabis should not be used by people with a personal or family history of psychosis, of another serious mental illness or of depression.
The Dutch pharmacist interviewed in the Primer lists schizophrenia among the known contraindications. He names three main risks in practice. The first is intoxication, meaning being too high. The second is triggering psychotic symptoms in people with a mental illness. The third is making existing depression worse.
Family history counts. Patients often brush it aside, but there is a real reason for it. THC-triggered psychosis happens mostly in people with an inherited vulnerability to it. Psychosis in a close relative is a rough but real sign that you may share that vulnerability.
Depression and bipolar disorder are more debated. Bipolar disorder means mood swings between low periods and unusually high, overactive periods. The Primer puts depression on the do-not-use side. Other sources treat it as a caution that needs monitoring rather than a reason to exclude someone. All sources agree on one point: the prescriber needs your mental health history before the first prescription, not after a bad reaction.
What to raise with a prescriber:
- any personal history of psychosis, schizophrenia, bipolar disorder, severe depression or a hospital stay for mental illness;
- any of the same conditions in your family;
- any past bad reaction to cannabis, even one from years ago and even from recreational use.
Translator’s note: a bad reaction from years ago can feel embarrassing to mention, especially if it happened during recreational use. Tell the prescriber anyway. It is medical information they need to choose a safe product. It is not a confession.
Heart and blood vessel disease
Cannabinoids have real effects on the heart and blood vessels, and these effects pull in two directions at once:
- soon after a dose, cannabis usually raises the heart rate;
- it also widens blood vessels in the body, so the vessels resist blood flow less and blood pressure falls.
Picture a heart whose arteries are already narrowed. It has little “coronary reserve”, meaning little ability to send more blood to the heart muscle when the heart works harder. A faster heartbeat needs more oxygen. At the same time, lower blood pressure pushes less blood through the narrowed arteries. The heart muscle then runs short of oxygen. Doctors call this myocardial ischaemia, and this is how cannabis can bring it on.
The Primer says people with a history of heart disease, or who take heart medicines, should avoid medical cannabis. If they do use it, it should be only under close medical supervision. The Dutch pharmacist lists arrhythmia (an irregular heartbeat) and other heart disease among the known contraindications.
The Dutch pain physician goes further about one route: smoking. Smoked cannabis is linked to a higher risk of heart attack and stroke. Part of this comes from the extra strain on the heart. Part comes from the carbon monoxide in smoke. Carbon monoxide binds to haemoglobin, the part of the blood that carries oxygen, and forms carboxyhaemoglobin. Blood with a lot of carboxyhaemoglobin carries less oxygen. His conclusion is clear: smoking is never recommended.
This separates the risk of the medicine from the risk of how it is taken. A vaporiser heats cannabis without burning it, so there are no combustion products. Vaporising does not remove THC’s effects on heart rate and blood pressure, though.
What to raise with a prescriber: any diagnosed heart condition, irregular heartbeat, previous heart attack or stroke, angina (chest pain when the heart muscle lacks oxygen), high blood pressure that is not under control, and every heart medicine you take.
Translator’s note: if you smoke cannabis now, tell the prescriber honestly and ask which other route would suit you. For anyone with heart disease, the route is one of the most useful things to discuss.
Liver disease
The liver is where the body breaks down and clears cannabinoids. THC is broken down mainly by the enzyme CYP2C9, with help from CYP3A4. CBD is broken down by CYP2C19 and CYP3A4. A damaged liver clears them more slowly. A standard dose then gives higher levels in the blood that last longer than intended.
The guidance here is not “do not use”. It is “monitor and set the dose to match”. A person with liver disease needs supervision to make sure the dose stays within what their liver can handle.
There is a second reason to check the liver. Abnormal liver tests have been reported as a side effect, mainly with CBD. In trials of the pharmaceutical CBD medicine Epidiolex, raised liver enzymes appeared mostly in patients who were also taking valproate. For this reason, prescribers test the liver before treatment starts and again later. The first test is called a baseline. As explained above, this check applies to CBD-predominant products as well.
What to raise with a prescriber: hepatitis (inflammation of the liver), cirrhosis (scarring of the liver), fatty liver disease, any abnormal liver blood test, and every other medicine that the liver clears, especially valproate.
Translator’s note: if you have not had a liver blood test recently, ask whether you need one before starting. The result gives a starting point to compare later tests with. Include any Thai herbal medicines and supplements on your medicine list. The prescriber cannot assess what they do not know about.
Older patients
Older patients react more strongly to THC’s effects on the mind and nervous system. They also react more strongly to orthostatic hypotension, which is the bigger danger because it causes falls. The Primer stresses this for older people who already fall easily and for people with dementia. It adds that if cannabis is judged suitable, older patients should start at low doses.
Orthostatic hypotension: how to recognise it and why THC raises the risk of falls
Orthostatic hypotension is a drop in blood pressure when you stand up. Within moments of getting up from a bed or chair, you feel dizzy or light-headed. Your vision may go grey or blurred, and you may need to grab something to stay upright.
THC widens blood vessels and lowers blood pressure, as explained in the heart section. Older people are more sensitive to this effect. If THC also makes them drowsy or slows their reactions, a dizzy moment can easily become a fall.
A fall is not a minor side effect for an eighty-year-old. It is often the start of a decline that does not reverse.
Translator’s note on Thai conditions: heat of 30–35 °C and not drinking enough water can both make the drop on standing worse. Heavy sweating in hot weather can lead to dehydration, which lowers blood pressure. Night is a risky time. An older patient may get up to use the bathroom in the dark, sometimes during a power cut. These steps lower the chance that a dizzy moment ends in a fall:
- sit on the edge of the bed for a moment before standing up;
- keep a torch or a battery night light next to the bed;
- drink enough water through the day, unless a doctor has told you to limit fluids;
- tell family members which signs to watch for in the first weeks, such as dizziness on standing or unusual sleepiness.
Other medicines that add to the drowsiness
Two more factors make this group harder to treat than the pharmacology alone suggests.
The first is polypharmacy, which means taking several medicines at the same time. Older people are more likely to do this. Many of these medicines cause drowsiness, and cannabis adds to it.
The second is an interaction the Dutch pain physician saw for himself. Sedation can become much stronger when cannabinoids are combined with other central nervous system depressants. These are medicines that slow the brain down, such as opioid painkillers. The effect was strongest in older patients. Both heavy drowsiness and hallucinations have been reported.
What to raise with a prescriber: your age, any falls or dizziness on standing, memory problems or dementia, and a complete list of your medicines, including sleeping tablets and opioid painkillers.
Before your appointment: a checklist for this part
Write these down before you see the prescriber. With this information, they can choose the product, dose and route with the full picture in front of them.
- Mental health: any personal or family history of psychosis, schizophrenia, bipolar disorder, severe depression or a hospital stay for mental illness, and any past bad reaction to cannabis.
- Heart: any heart diagnosis, irregular heartbeat, heart attack, stroke, angina, uncontrolled blood pressure and all heart medicines. Also say whether you smoke cannabis now.
- Liver: hepatitis, cirrhosis, fatty liver, abnormal liver tests, valproate and other medicines the liver clears.
- Age and falls: past falls, dizziness on standing, dementia, sleeping tablets and opioid painkillers.
Part 2 covers substance use disorder, children and teenagers, interactions with other medicines, driving, and pregnancy and breastfeeding. It ends with a summary table of every group.
If a prescriber has changed your treatment because of something on this list, please describe what changed and why in a reply below. Examples are a lower starting dose, a switch to a CBD-predominant product or a different route. Your account can help other readers. Please do not post doses. Post the reasoning.
This article is general information, not medical advice. It does not replace an assessment by a practitioner authorised to prescribe under PT 33.
References
- Woodbridge, Martin. A Primer to Medicinal Cannabis. Bedrocan, 2018. Includes interviews with a Dutch pain physician and a Dutch dispensing pharmacist.
- Clinical trials of pharmaceutical CBD (Epidiolex): raised liver enzymes occurred mostly in patients also taking valproate. The original article names no individual trial.
Continued in Part 2: Contraindications and Cautions for Medical Cannabis: Substance Use, Children, Drug Interactions, Driving and Pregnancy (Part 2 of 2)